Long COVID remains a frustrating medical mystery, affecting up to 1 in 10 people long after the initial infection fades. Now, scientists have uncovered a crucial clue hidden deep within the immune ...

A T-cell response, or cellular immunity, was present in 100 people six months after their initial COVID-19 infection, according to a study published in the preprint server BioRxiv. Researchers from ...

The immune systems of some people who have not been exposed to the novel coronavirus could have some familiarity with the pathogen -- possibly helping to reduce the severity of illness if that person ...

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes a respiratory illness with systemic immune cell activation, inflammation, widespread multiorgan dysfunction, and thrombosis.

RNA vaccines saved millions of lives during COVID-19 but have limitations like waning immunity and complex production.

BA.3.2 Omicron variant appears in US traveller; scientists track spread, symptoms, and risk of unseen outbreaks across ...

Detailed price information for Geovax Labs Inc (GOVX-Q) from The Globe and Mail including charting and trades.

Discover the science behind the sudden spread of the COVID-19 "Cicada" variant, its unique symptoms, and how it evades ...

Here is everything you need to know about the Cicada variant and what its arrival means for your health this season.